Particularly in CRC, specificity of PHD inhibitors is warranted because PHD2 inhibition has been shown to increase tumor growth and PHD3 blockage has been associated with a reduced apoptotic response to irradiation (Chan et al, 2009; Xie et al, 2012). The gene discussed is EGLN3; the disease is neoplasm.